"An Ounce of Prevention…"
- PMID: 40091848
- DOI: 10.1002/mus.28395
"An Ounce of Prevention…"
Keywords: Duchenne muscular dystrophy; angiotensin‐converting enzyme inhibitor; cardiomyopathy; heart failure.
References
-
- L. Passamano, A. Taglia, A. Palladino, et al., “Improvement of Survival in Duchenne Muscular Dystrophy: Retrospective Analysis of 835 Patients,” Acta Myologica 31, no. 2 (2012): 121–125, https://www.ncbi.nlm.nih.gov/pubmed/23097603.
-
- L. Wahlgren, A. K. Kroksmark, M. Tulinius, and K. Sofou, “One in Five Patients With Duchenne Muscular Dystrophy Dies From Other Causes Than Cardiac or Respiratory Failure,” European Journal of Epidemiology 37, no. 2 (2022): 147–156, https://doi.org/10.1007/s10654‐021‐00819‐4.
-
- C. Villa, S. R. Auerbach, N. Bansal, et al., “Current Practices in Treating Cardiomyopathy and Heart Failure in Duchenne Muscular Dystrophy (DMD): Understanding Care Practices in Order to Optimize DMD Heart Failure Through ACTION,” Pediatric Cardiology 43, no. 5 (2022): 977–985, https://doi.org/10.1007/s00246‐021‐02807‐7.
-
- C. Spurney, R. Shimizu, L. P. Morgenroth, et al., “Cooperative International Neuromuscular Research Group Duchenne Natural History Study Demonstrates Insufficient Diagnosis and Treatment of Cardiomyopathy in Duchenne Muscular Dystrophy,” Muscle & Nerve 50, no. 2 (2014): 250–256, https://doi.org/10.1002/mus.24163.
-
- C. A. Wittlieb‐Weber, K. R. Knecht, C. R. Villa, et al., “Risk Factors for Cardiac and Non‐Cardiac Causes of Death in Males With Duchenne Muscular Dystrophy,” Pediatric Cardiology 41, no. 4 (2020): 764–771, https://doi.org/10.1007/s00246‐020‐02309‐y.
Publication types
LinkOut - more resources
Full Text Sources